Search

Author/Creator Yang, X.

2. 165P Efficacy and safety of tislelizumab (TIS) plus lenvatinib (LEN) as first-line treatment in patients (pts) with unresectable hepatocellular carcinoma (uHCC): A single-arm, multicenter, phase II trial. (December 2022)

Authors:
Xu, L.; Chen, J.; Yang, J.; Gong, W.; Zhang, Y.; Zhao, H.; Yan, S.; Jia, W.; Wu, Z.; Liu, C.; Song, X.; Ma, Y.; Yang, X.; Gao, Z.; Zhang, N.; Zheng, X.; Li, M.; Zhang, X.; Chen, M.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 201P Phase II study of taminadenant (A2AR antagonist) + spartalizumab (anti PD-1 antibody) in patients with triple-negative breast cancer (TNBC). (December 2022)

Authors:
Jerusalem, G.; De Braud, F.G.M.; de Jonge, M.J.A.; Grell, P.; Gonçalves, A.; Tan, T.J.Y.; Greil, R.; Yap, T.A.; Lin, C-C.; Kornbluth, K.A.; Yang, X.; Vong, C.; Choudhury, S.; Mataraza, J.; Lee, L.H.; Otero, J.A.; Garralda, E.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 2925 Expression of the Epithelial-Mesenchymal-Transition (EMT) markers, Twist, Slug, Snail, E- and N-cadherins and the association with clinical and pathological features of human pituitary adenomas. (September 2015)

Authors:
Jia, W.; Zhu, J.; Martin, T.A.; Sanders, A.J.; Yang, X.; Cheng, S.; Yu, H.; Jia, G.; Jiang, W.G.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S592
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 2MO First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in metastatic non-small cell lung cancer (mNSCLC): Clinical outcomes and biomarker analyses from CheckMate 592. (December 2022)

Authors:
Gettinger, S.; Schenker, M.; De Langen, J.; Fischer, J.R.; Morgensztern, D.; Ciuleanu, T-E.; Beck, T.; De Castro Carpeno, J.; Schumann, C.; Yang, X.; Telivala, B.; Deschepper, K.; Nadal, E.; Schalper, K.; Spires, T.; Balli, D.; Nassar, A.; Karam, S.; Bhingare, A.; Spigel, D.R.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗